News
GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...
Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
She lost 250 pounds and thought her journey was over... but then she discovered something most people don't talk about.
Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.
New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...
Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, with many patients quitting GLP-1 treatment within a year.
Back in May 2025, dapiglutide failed to impress in a phase 2 trial, mustering up to an average 4.3% reduction in weight loss when given at the 6 mg dose. The 54-person study involved administering ...
“GLP-1 drugs don’t just curb appetite – they dull the desire to drink at a metabolic level. With cravings suppressed and ...
Popular weight loss drugs such as Wegovy and Zepbound have shown incredible success in clinical trials. But in the real world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results